SIREN : 490598216
OMNIMED is a French company founded 19 years ago, specialized in the sector Activités des marchands de biens immobiliers. Based in MARSEILLE (13004), this company of category PME shows in 2018 a revenue of 944 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | 944 273 € | 1 037 121 € | 1 037 526 € |
| Net income | 125 009 € | 82 959 € | 109 167 € | 4 099 € | -9 341 € | -5 073 € | 53 185 € | 105 191 € |
| EBITDA | N/C | N/C | N/C | N/C | N/C | 365 326 € | 438 208 € | 434 541 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | -0.5% | 5.1% | 10.1% |
In 2023, OMNIMED generates positive net income of 125 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 105 k€ -> 125 k€.
125 009 €
The debt ratio (= Financial debt / Equity x 100) stands at 87%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
87.182%
51.511%
49.4%
In 2023, the debt ratio of OMNIMED (87.18) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of OMNIMED (51.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 178.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
178.026
In 2023, the liquidity ratio of OMNIMED (178.03) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (21 transactions). This range of 571 051€ to 1 711 292€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 21 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare OMNIMED with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des marchands de biens immobiliers
The revenue of OMNIMED in 2018 is 944 k€.
Yes, OMNIMED generated a net profit of 125 k€ in 2023.
The headquarters of OMNIMED is located in MARSEILLE (13004), in the department Bouches-du-Rhone.
The tax return of OMNIMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
OMNIMED operates in the sector Activités des marchands de biens immobiliers (NAF code 68.10Z). See the 'Sector positioning' section above to compare the company with its competitors.